Xerox Holdings Corp false 0001770450 0001770450 2021-05-20 2021-05-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 20, 2021

 

 

 

XEROX HOLDINGS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

New York   001-39013   83-3933743
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

201 Merritt 7

Norwalk, Connecticut

06851

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (203) 849-5216

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol

 

Name of each exchange
on which registered

Xerox Holdings Corporation

Common Stock, $1 par value

  XRX   New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the Annual Meeting of Shareholders held on May 20, 2021, Registrant’s shareholders voted to approve Registrant’s amended and restated Equity Compensation Plan for Non-Employee Directors (the “Plan”). The Plan was amended and restated primarily to increase, by 500,000 shares, the number of shares of Registrant’s common stock reserved for issuance under the Plan and to include a limitation on the annual total non-employee director compensation of $750,000, covering both annual cash retainers and annual equity retainers. A copy of the Plan is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. The foregoing does not purport to be a complete description of the terms of the Plan, and is qualified in its entirety by reference to the Plan.

 

2


Item 5.07 Submission of Matters to a Vote of Security Holders.

 

(a)

On May 20, 2021, Registrant held its Annual Meeting of Shareholders.

 

(b)

Shareholders voted on the matters set forth below as follows:

1.    Election of directors. All nominees for director were elected.

 

Name

   For    Against    Abstain    Non Votes

Keith Cozza

   148,437,572    1,679,663    232,428    14,912,841

Joseph J. Echevarria

   142,317,866    7,801,478    230,319    14,912,841

Cheryl G. Krongard

   125,677,750    24,448,940    222,972    14,912,841

Scott Letier

   131,325,835    18,785,767    238,061    14,912,841

Nichelle Maynard-Elliott

   149,301,743    819,565    228,018    14,912,841

Steven D. Miller

   148,748,709    1,337,472    263,482    14,912,841

James L. Nelson

   138,056,702    12,051,679    241,282    14,912,841

Margarita Paláu-Hernández

   141,903,159    8,206,920    239,584    14,912,841

Giovanni (“John”) Visentin

   149,318,273    784,899    246,491    14,912,841

2.    Ratification of selection of PricewaterhouseCoopers LLP as Registrant’s independent registered public accounting firm for 2021. The selection of PricewaterhouseCoopers LLP was ratified.

 

For

 

Against

 

Abstain

 

Non Votes

161,642,115

  3,382,387   237,610   0

3.    Approval, on an advisory basis, of the 2020 compensation of Registrant’s Named Executive Officers, as disclosed in Registrant’s 2021 Proxy Statement. The 2020 compensation of Registrant’s Named Executive Officers, as disclosed in Registrant’s 2021 Proxy Statement, was not approved on an advisory basis.

 

For

 

Against

 

Abstain

 

Non Votes

45,665,167

  103,841,116   843,380   14,912,841

4.    Proposal to approve the Company’s amended and restated Equity Compensation Plan for Non-Employee Directors. The proposal to approve the Company’s amended and restated Equity Compensation Plan for Non-Employee Directors was approved.

 

For

 

Against

 

Abstain

 

Non Votes

146,041,880

  3,892,075   415,683   14,912,841

 

3


5.    Shareholder Proposal for shareholder action by written consent, if properly presented to the meeting. The proposal to approve shareholder action by written consent was approved.

 

For

 

Against

 

Abstain

 

Non Votes

95,104,033

  24,961,039   30,284,292   14,912,841

6.    Election of Aris Kekedjian as a Director. The proposal to elect Aris Kekedjian as a Director was approved.

 

For

 

Against

 

Abstain

 

Non Votes

142,604,480

  6,138,481   318,159   16,103,594

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.
   Description of Exhibit
10.1    Registrant’s Amended and Restated Equity Compensation Plan for Non-Employee Directors (2021 Restatement).
104    Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

 

4


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Registrant has duly authorized this Report to be signed on its behalf by the undersigned duly authorized.

 

    XEROX HOLDINGS CORPORATION  
    By:  

/s/ Douglas H. Marshall

 
      Douglas H. Marshall  
Date: May 25, 2021       Secretary  

 

5